Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLISWITCH
NCT07529236Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Apr 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of ustekinumab in Crohn's disease, ulcerative colitis (UC) and psoriasis, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Proportion of patients maintaining UC or CD control at 6 months. Started Apr 2026; status: recruiting.
02
Drugs
ustekinumab
03
Conditions
Crohn's diseaseulcerative colitis (UC)psoriasis
Beyond the preview
Go deeper on NCT07529236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07529236.